A Tougher Pill to Swallow: Roundtable on Generic Drugs
![The Accad & Koka Report](https://cdn.mises.org/styles/responsive_4_3_650w/s3/static-page/img/TheAccad%26KokaReport_750x516_v2_20181129.png.webp?itok=xcYJg8wj 650w,https://cdn.mises.org/styles/responsive_4_3_870w/s3/static-page/img/TheAccad%26KokaReport_750x516_v2_20181129.png.webp?itok=4tA-5gSL 870w,https://cdn.mises.org/styles/responsive_4_3_1090w/s3/static-page/img/TheAccad%26KokaReport_750x516_v2_20181129.png.webp?itok=HI4f-Rqa 1090w,https://cdn.mises.org/styles/responsive_4_3_1310w/s3/static-page/img/TheAccad%26KokaReport_750x516_v2_20181129.png.webp?itok=gL8uwCsq 1310w,https://cdn.mises.org/styles/responsive_4_3_1530w/s3/static-page/img/TheAccad%26KokaReport_750x516_v2_20181129.png.webp?itok=H1UV-41Y 1530w)
As a follow-up to the episode on the Ranbaxy Scandal, Accad and Koka are joined by medicinal chemist John Tucker, PhD, and hypertension specialist Swapnil Hiremath, MD. The guests share their perspectives and impressions on the unsettling question of generic drugs.